drugset / Trial / NCT06120439
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this randomized controlled trial (RCT) is to assess the Quality of Recovery (QoR) in Breast-conserving Surgery (BCS) with Sentinel Lymph Node Biopsy (SLNB) using Pectoral Nerves (PECS) Block and General Anesthesia (GA). The primary objectives are as follows: First, to determine if the PECS group exhibits better QoR; Second, to investigate if the PECS group experiences less postoperative pain and complications; Third, to examine if the PECS group demonstrates more stable hemodynamics.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-05-11
- Completion
- 2024-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Midazolam | Small molecule | 0.05 mg/kg | Intravenous |
| Background | Propofol | Small molecule | 3 ug/ml | — |
| Background | Propofol | Small molecule | 4 ug/ml | — |
| Background | Remifentanil | Small molecule | 1 ng/ml | — |
| Background | Remifentanil | Small molecule | 2 ng/ml | — |
| Background | Rocuronium | Other / unclassified | 0.6 mg/kg | Intravenous |
| Background | Ropivacaine | Other / unclassified | 0.3 % | Other |
| Background | Sufentanil | Other / unclassified | 0.3 ug/kg | Intravenous |